Bank of New York Mellon
AURA icon

Bank of New York Mellon’s Aura Biosciences AURA Stock Holding History

Bank of New York Mellon’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$842K Buy
118,593
+19,160
+19% +$137K ﹤0.01% 3466
2026
Q1 		$665K Sell
99,433
-8,490
-8% -$48.7K ﹤0.01% 3455
2025
Q4 		$588K Buy
107,923
+12,187
+13% +$72.4K ﹤0.01% 3517
2025
Q3 		$592K Buy
95,736
+2,455
+3% +$16.1K ﹤0.01% 3499
2025
Q2 		$584K Sell
93,281
-13,770
-13% -$80.5K ﹤0.01% 3424
2025
Q1 		$627K Buy
107,051
+781
+0.7% +$5.91K ﹤0.01% 3338
2024
Q4 		$874K Buy
106,270
+344
+0.3% +$3.24K ﹤0.01% 3231
2024
Q3 		$944K Sell
105,926
-37,101
-26% -$318K ﹤0.01% 3171
2024
Q2 		$1.08M Buy
143,027
+48,549
+51% +$356K ﹤0.01% 3154
2024
Q1 		$742K Buy
94,478
+4,193
+5% +$34.8K ﹤0.01% 3310
2023
Q4 		$800K Buy
90,285
+6,442
+8% +$54.6K ﹤0.01% 3310
2023
Q3 		$752K Buy
83,843
+1,120
+1% +$12K ﹤0.01% 3340
2023
Q2 		$1.02M Buy
82,723
+18,064
+28% +$193K ﹤0.01% 3187
2023
Q1 		$600K Buy
64,659
+14,563
+29% +$151K ﹤0.01% 3394
2022
Q4 		$526K Sell
50,096
-240
-0.5% -$3.06K ﹤0.01% 3518
2022
Q3 		$912K Buy
50,336
+10,240
+26% +$155K ﹤0.01% 3252
2022
Q2 		$569K Buy
40,096
+25,600
+177% +$424K ﹤0.01% 3513
2022
Q1 		$319K Buy
+14,496
New +$276K ﹤0.01% 3982

Other funds holding AURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return

Bank of New York Mellon's AURA Position: Q2 2026 in Review

Bank of New York Mellon increased its Aura Biosciences (AURA) stake by 19% in Q2 2026, buying an estimated $137K and bringing the position to 118,593 shares worth $842K. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Bank of New York Mellon first reported a position in AURA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.08M in Q2 2024. 63 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Bank of New York Mellon held 118,593 shares of Aura Biosciences worth $842K as of Q2 2026.
  • Bank of New York Mellon bought 19,160 Aura Biosciences shares in Q2 2026, an estimated $137K.
  • Aura Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3466 holding.
  • Bank of New York Mellon first reported a position in Aura Biosciences in Q1 2022 and has held it in 18 quarters since.
  • Bank of New York Mellon's Aura Biosciences position peaked at $1.08M in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.